CR20160339A - ANTI-VISTA ANTIBODIES AND FRAGMENTS - Google Patents

ANTI-VISTA ANTIBODIES AND FRAGMENTS

Info

Publication number
CR20160339A
CR20160339A CR20160339A CR20160339A CR20160339A CR 20160339 A CR20160339 A CR 20160339A CR 20160339 A CR20160339 A CR 20160339A CR 20160339 A CR20160339 A CR 20160339A CR 20160339 A CR20160339 A CR 20160339A
Authority
CR
Costa Rica
Prior art keywords
fragments
methods
vista antibodies
vista
melanomas
Prior art date
Application number
CR20160339A
Other languages
Spanish (es)
Inventor
Gordon Powers
Linda Snyder
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Priority claimed from PCT/IB2014/002868 external-priority patent/WO2015097536A2/en
Publication of CR20160339A publication Critical patent/CR20160339A/en

Links

Abstract

La presente invención se refiere a nuevos anticuerpos y fragmentos que se unen al dominio V de la Ig supresora de la activación de linfocitos T (VISTA), y métodos para preparar y usar los mismos. Los métodos de uso incluyen métodos de tratamiento del cáncer, incluyendo leucemias, linfomas, tumores sólidos y melanomas.The present invention relates to new antibodies and fragments that bind to the V domain of the T-cell activation suppressor Ig (VISTA), and methods for preparing and using them. Methods of use include methods of cancer treatment, including leukemia, lymphomas, solid tumors and melanomas.

CR20160339A 2013-12-24 2014-12-22 ANTI-VISTA ANTIBODIES AND FRAGMENTS CR20160339A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361920695P 2013-12-24 2013-12-24
US201461085086P 2014-11-26 2014-11-26
PCT/IB2014/002868 WO2015097536A2 (en) 2013-12-24 2014-12-22 Anti-vista antibodies and fragments

Publications (1)

Publication Number Publication Date
CR20160339A true CR20160339A (en) 2016-10-05

Family

ID=59676281

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160339A CR20160339A (en) 2013-12-24 2014-12-22 ANTI-VISTA ANTIBODIES AND FRAGMENTS

Country Status (1)

Country Link
CR (1) CR20160339A (en)

Similar Documents

Publication Publication Date Title
ECSP16062894A (en) ANTIBODIES AND ANTI-VISION FRAGMENTS
CO2017010618A2 (en) Antibodies against icos
BR112016007891A2 (en) use of cbp / ep300 bromodomain inhibitors for cancer immunotherapy
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
UY36452A (en) NEW MODULATING FXR COMPOUNDS (NR1H4)
CL2016000388A1 (en) Composition of 6 mRNA coding for 5t4 (tpbg, survivin (birc5), ny-eso-1 (ctag1b), mage-c1, mage-c2 and muc1 and vaccine to make a useful medication to treat lung cancer
UY36445A (en) FXR MODULATING COMPOUNDS (NR1H4 CONTAINING HYDROXY GROUPS)
CL2016000925A1 (en) Bromodomain inhibitors
BR112016017256A2 (en) combination of a pd-1 antagonist and a vegfr inhibitor for cancer treatment
CL2015003280A1 (en) Benzimidazole derivatives as bromodomain inhibitors
CL2016002667A1 (en) Novel anti-rnf43 antibodies and methods for use
GT201400297A (en) NEW TIENOPIRIMIDINE DERIVATIVES, A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY35500A (en) INDAZOLS REPLACED WITH HETEROARILO
BR112017017700A2 (en) cancer treatment methods, compositions and kits
CL2018001722A1 (en) New anti-mfi2 antibodies and methods of use (divisional application 201700506)
BR112016017112A2 (en) APILIMOD COMPOSITIONS AND METHODS OF USE THEREOF
BR112016029842A2 (en) anti-cd22-drug antibody conjugates and methods of use
CL2016000038A1 (en) Pyroxolo-substituted pyridinamines
BR112015032526A2 (en) anti-dandruff compositions and methods of use thereof
NI201500175A (en) NEW COMPOUNDS FOR THE TREATMENT OF CANCER
EA201591709A1 (en) 5-BROMED INDIRUBINES
JOP20150008B1 (en) Anti-vista antibodies and fragments
BR112019023742A2 (en) anti-trkb antibodies
UY35823A (en) NMDA ANTAGONIST PROPHARMS
CR20160339A (en) ANTI-VISTA ANTIBODIES AND FRAGMENTS